hiv combo + abbott award

8/3/2019 HIV Combo + Abbott Award

1/3

5/16/11 9:22 PRCHITECT HIV Ag/Ab Combo Test Wins Prestigious Chicago Innovation Award - KUAM.com-KUAM News: On Air. Online. On Demand.

Page 1tp://www.kuam.com/story/13436851/architect-hiv-agab-combo-test-wins-prestigious-chicago-innovation-award?redirected=true

MEMBER CENTER: Create Account | Log In SITE SEARCH WEB SEARCH BY

Email Share | Print Text Size

ARCHITECT HIV Ag/Ab Combo Test Wins Prestigious Chicago

Innovation AwardRecommend Be the first of your friends to recommend this.

Inf ormati o n co ntain ed on this page is provided by companies via pressrelease distributed through PR Newswire, an independent third-party content provider. PR Ne wswire, WorldNow and this Station make nowarranties or represent ations in connection therewith.

SOURCE Abbott

Fifth I nnovatio n Award for Ab b ott in Seve n Yea rs R ecog nizesInno va tive Tes t for Ea rli er Det e ction of HI V

ABBOTT PARK, Ill., Nov. 3, 2010 /PRNewswire/ -- Abbott todayannounced it has received a 2010 Chicago Innovation Award for its

ARCHITECT HIV Ag/Ab Combo assay, the first test approved in theUnited States that can simultaneously detect both HIV antigens and

antibodies.

The HIV Ag/Ab Combo test was approved by the U.S. Food and Drug Administration and launched inSeptember 2010, allowing patients to be diagnosed earlier than ever before. Studies conducted by theCenters for Disease Control and Prevention (CDC) show that current antibody-only tests miss 10.5percent of HIV infections in some high-risk populations because they do not detect antigens. However,Abbott's new assay detects the HIV p24 antigen, or the direct presence of HIV, allowing for diagnosisof early infections days before antibodies emerge, which is important in controlling the spread of theinfection.

"Receiving the Chicago Innovation Award is a great testament to Abbott's constant pursuit of innovation, which is driven by the search for meaningful solutions like the HIV Combo test for thepatients who rely on us," said Edward L. Michael, executive vice president, diagnostic products, Abbott.

This is the fifth Chicago Innovation Award that Abbott has received in seven years. Most recently, itsXIENCE V Everolimus Eluting Coronary Stent System received the honor in 2008. In 2007, theAbbott m 2000 molecular diagnostic instrument in combination with the RealTime HIV-1 viral loadtest received the honor. In 2005, the company's PathVysion breast cancer test received the honor,and in 2003, HUMIRA, a biologic treatment for certain immunological diseases, won the award. Inaddition, Abbott's Similac SimplePac container won the Chicago Innovation Award's first-everPeople's Choice Award in the 2009.

This is the latest recognition for Abbott's scientific innovation. Abbott's MitraClip system, aninvestigational device used for catheter-based mitral valve repair, was recognized in The Wall Street

Journal's 2010 Technology Innovation Awards. In 2009, Abbott's PLEX-ID was the overall Gold winnerof The Wall Street Journal Technology Innovation Awards; it was also named one of the top scientificinnovations by The Scientist magazine. Abbott also has earned recognition as one of the best placesfor scientists to work from The Scientist and Science magazines.

Sponsored by Kuczmarski and Associates and BusinessWeek , the Chicago Innovation Awards createawareness of the contributions of Chicago-area companies and organizations in developing innovative

See what the stars hold for you

Check your daily forecastDaily love horoscopesDaily career horoscopesYour finances, by signZodiac dating guide
http://ad.doubleclick.net/click%3Bh%3Dv8/3b0a/3/0/%2a/j%3B241006097%3B0-0%3B0%3B38217911%3B896-300/75%3B42069881/42087668/1%3B%3B~sscs%3D%3fhttp://www.kuam.com/Global/category.asp?C=65234http://www.kuam.com/Global/Create_Email_Story.asp?s=13436851&Headline=ARCHITECT%20HIV%20Ag%2FAb%20Combo%20Test%20Wins%20Prestigious%20Chicago%20Innovation%20Award&pageurl=architect-hiv-agab-combo-test-wins-prestigious-chicago-innovation-award&creationdate=2010/11/03http://addthis.com/bookmark.php?v=250&username=xa-4bbcc485014c0ab2http://www.addthis.com/bookmark.php?v=250&winname=addthis&pub=xa-4a6f307d7c62c8a7&source=tbx-250&lng=en-us&s=facebook&url=http%3A%2F%2Fwww.kuam.com%2Fstory%2F13436851%2Farchitect-hiv-agab-combo-test-wins-prestigious-chicago-innovation-award%3Fredirected%3Dtrue&title=ARCHITECT%20HIV%20Ag%2FAb%20Combo%20Test%20Wins%20Prestigious%20Chicago%20Innovation%20Award%20-%20KUAM.com-KUAM%20News%3A%20On%20Air.%20Online.%20On%20Demand.&ate=AT-xa-4a6f307d7c62c8a7/-/-/4dd1db82b8dc2d3d/1&uid=4dd1db820de6a6d3&pre=http%3A%2F%2Fwww.google.com%2Furl%3Fsa%3Dt%26source%3Dweb%26cd%3D5%26ved%3D0CDEQFjAE%26url%3Dhttp%253A%252F%252Fwww.kuam.com%252Fstory%252F13436851%252Farchitect-hiv-agab-combo-test-wins-prestigious-chicago-innovation-award%253Fredirected%253Dtrue%26rct%3Dj%26q%3DHIV%2520combo%2520abbott%2520award%26ei%3DP9vRTeL4Iofb0QHdipzpCw%26usg%3DAFQjCNFPTRBVfME2RtZARjNvuXWCO&tt=0http://www.kuam.com/story/13436851/architect-hiv-agab-combo-test-wins-prestigious-chicago-innovation-award?clienttype=printablehttp://ad.doubleclick.net/click%3Bh%3Dv8/3b0a/3/0/%2a/d%3B227891106%3B0-0%3B0%3B37427884%3B1-468/60%3B39866428/39884215/1%3B%3B~sscs%3D%3fhttp://www.takecareasia.comhttp://ad.doubleclick.net/click%3Bh%3Dv8/3b0a/3/0/%2a/d%3B227891106%3B0-0%3B0%3B37427884%3B1-468/60%3B39866428/39884215/1%3B%3B~sscs%3D%3fhttp://www.takecareasia.comhttp://www.kuam.com/videohttp://www.kuam.com/category/172112/weekly-features-nav-barhttp://www.kuam.com/category/164102/communityhttp://www.kuam.com/category/168059/promotionshttp://www.kuam.com/weatherhttp://www.kuam.com/category/68446/lifestylehttp://www.kuam.com/link/394943/embedded-nbc-media-playerhttp://www.kuam.com/link/394942/embedded-cbs-media-playerhttp://www.kuam.com/category/169968/about-ushttp://www.kuam.com/videohttp://www.kuam.com/category/172112/weekly-features-nav-barhttp://www.kuam.com/category/164102/communityhttp://www.kuam.com/category/168059/promotionshttp://www.kuam.com/weatherhttp://www.kuam.com/category/68446/lifestylehttp://ad.doubleclick.net/click%3Bh%3Dv8/3b0a/3/0/%2a/j%3B241006097%3B0-0%3B0%3B38217911%3B896-300/75%3B42069881/42087668/1%3B%3B~sscs%3D%3fhttp://www.kuam.com/Global/category.asp?C=64787http://ad.doubleclick.net/click%3Bh%3Dv8/3b0a/3/0/%2a/j%3B241006097%3B0-0%3B0%3B38217911%3B896-300/75%3B42069881/42087668/1%3B%3B~sscs%3D%3fhttp://www.kuam.com/Global/category.asp?C=65441http://ad.doubleclick.net/click%3Bh%3Dv8/3b0a/3/0/%2a/j%3B241006097%3B0-0%3B0%3B38217911%3B896-300/75%3B42069881/42087668/1%3B%3B~sscs%3D%3fhttp://www.kuam.com/Global/category.asp?C=65238http://ad.doubleclick.net/click%3Bh%3Dv8/3b0a/3/0/%2a/j%3B241006097%3B0-0%3B0%3B38217911%3B896-300/75%3B42069881/42087668/1%3B%3B~sscs%3D%3fhttp://www.kuam.com/Global/category.asp?C=65234http://ad.doubleclick.net/click%3Bh%3Dv8/3b0a/3/0/%2a/j%3B241006097%3B0-0%3B0%3B38217911%3B896-300/75%3B42069881/42087668/1%3B%3B~sscs%3D%3fhttp://www.kuam.com/Global/category.asp?C=1397http://ad.doubleclick.net/click%3Bh%3Dv8/3b0a/3/0/%2a/d%3B227891106%3B0-0%3B0%3B37427884%3B1-468/60%3B39866428/39884215/1%3B%3B~sscs%3D%3fhttp://www.takecareasia.comhttp://ad.doubleclick.net/click;h=v8/3b0a/0/0/%2a/m;44306;0-0;0;37427884;9289-490/25;0/0/0;;~sscs=%3fhttp://ad.doubleclick.net/click;h=v8/3b0a/0/0/%2a/f;44306;0-0;0;37427884;2928-180/150;0/0/0;;~sscs=%3fhttp://www.kuam.com/story/13436851/architect-hiv-agab-combo-test-wins-prestigious-chicago-innovation-award?clienttype=printablehttp://www.addthis.com/bookmark.php?v=250&winname=addthis&pub=xa-4a6f307d7c62c8a7&source=tbx-250&lng=en-us&s=facebook&url=http%3A%2F%2Fwww.kuam.com%2Fstory%2F13436851%2Farchitect-hiv-agab-combo-test-wins-prestigious-chicago-innovation-award%3Fredirected%3Dtrue&title=ARCHITECT%20HIV%20Ag%2FAb%20Combo%20Test%20Wins%20Prestigious%20Chicago%20Innovation%20Award%20-%20KUAM.com-KUAM%20News%3A%20On%20Air.%20Online.%20On%20Demand.&ate=AT-xa-4a6f307d7c62c8a7/-/-/4dd1db82b8dc2d3d/1&uid=4dd1db820de6a6d3&pre=http%3A%2F%2Fwww.google.com%2Furl%3Fsa%3Dt%26source%3Dweb%26cd%3D5%26ved%3D0CDEQFjAE%26url%3Dhttp%253A%252F%252Fwww.kuam.com%252Fstory%252F13436851%252Farchitect-hiv-agab-combo-test-wins-prestigious-chicago-innovation-award%253Fredirected%253Dtrue%26rct%3Dj%26q%3DHIV%2520combo%2520abbott%2520award%26ei%3DP9vRTeL4Iofb0QHdipzpCw%26usg%3DAFQjCNFPTRBVfME2RtZARjNvuXWCO&tt=0http://addthis.com/bookmark.php?v=250&username=xa-4bbcc485014c0ab2http://www.kuam.com/Global/Create_Email_Story.asp?s=13436851&Headline=ARCHITECT%20HIV%20Ag%2FAb%20Combo%20Test%20Wins%20Prestigious%20Chicago%20Innovation%20Award&pageurl=architect-hiv-agab-combo-test-wins-prestigious-chicago-innovation-award&creationdate=2010/11/03http://www.kuam.com/category/169968/about-ushttp://www.kuam.com/link/394942/embedded-cbs-media-playerhttp://www.kuam.com/link/394943/embedded-nbc-media-playerhttp://www.kuam.com/category/68446/lifestylehttp://www.kuam.com/weatherhttp://www.kuam.com/category/168059/promotionshttp://www.kuam.com/category/164102/communityhttp://www.kuam.com/category/172112/weekly-features-nav-barhttp://www.kuam.com/videohttp://www.kuam.com/category/168038/radiohttp://www.kuam.com/category/191903/decision-2010-nav-barhttp://www.kuam.com/category/164101/sportshttp://www.kuam.com/category/164100/newshttp://www.kuam.com/http://%20wnmembercentermanager.gotologinlink%28%27login%27%29/http://%20wnmembercentermanager.gotologinlink%28%27create%27%29/


2/3



products and services that uniquely fill unmet needs and change lives. Abbott and other awardeeswere recognized at a ceremony and reception at the Goodman Theatre attended by approximately 800local business, academic and government leaders.

Important Product Usage and Safety Information

The ARCHITECT HIV Ag/Ab Combo assay is a chemiluminescent microparticle immunoassay (CMIA) forthe simultaneous qualitative detection of human immunodeficiency virus (HIV) p24 antigen andantibodies to HIV type 1 (HIV-1 group M and group O) and/or type 2 (HIV-2) in human serum andplasma (EDTA and heparin). The ARCHITECT HIV Ag/Ab Combo assay is intended to be used as an aidin the diagnosis of HIV-1/HIV-2 infection, including acute or primary HIV-1 infection. The assay mayalso be used as an aid in the diagnosis of HIV-1/HIV-2 infection in pediatric subjects (i.e., children asyoung as two years of age) and in pregnant women. An ARCHITECT HIV Ag/Ab Combo reactive resultdoes not distinguish between the detection of HIV p24 antigen, HIV-1 antibody, or HIV-2 antibody.

The ARCHITECT HIV Ag/Ab Combo is not intended for use in screening blood or plasma donors. Theeffectiveness of ARCHITECT HIV Ag/Ab Combo for use in screening blood or plasma donors has notbeen established. However, this assay can be used as a blood donor screening assay in urgentsituations where traditional licensed blood donor screening tests are unavailable or their use isimpractical. The performance of this assay has not been established for individuals younger than twoyears of age. Definitive diagnosis of HIV infection in early infancy requires other assays. Assay resultsshould be interpreted in conjunction with the patient's clinical presentation, history, and otherlaboratory results. If the results are inconsistent with clinical evidence, additional testing is suggestedto confirm the result. This product requires the handling of human specimens. It is recommended thatthese reagents and human specimens be handled in accordance with the OSHA Standard onBloodborne Pathogens. Assay specific information is presented in the assay package insert which canbe accessed at www.abbottdiagnostics.com once the product is available.

About Abbott

Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery,development, manufacture and marketing of pharmaceuticals and medical products, includingnutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets itsproducts in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site atwww.abbott.com .

2010 PR Newswire. All Rights Reserved.
http://www.abbott.com/http://www.abbottdiagnostics.com/


3/3



AdvertisementFlower Mound - Newrick allows any Texas

resident to getextremely cheap car insurance.

Refinance now at2.6%. $160,000 Texasmortgage $659/mo. Nossn req. (2.9% apr)

Texas: Mom discovers$9 car insurance trick.Auto insurers arescared you will learn

his too.

People are buying their dream home with helpfrom penny stocks...

Shocking discovery byCambridge researchersfor amazing jointrelief...

Learn about newprogram credit cardcompanies don't wantyou to know about willeliminate your debt.

All content Copyright 2000-2009, WorldNow and KUAM. All Rights Reserved.For more information on this site, please read our Privacy Policy and Terms of Service.
http://www.kuam.com/global/story.asp?s=18991http://www.kuam.com/global/story.asp?s=18990http://web.adblade.com/clicks.php?appId=3243&zid=4da5904ab8406&adId=26507&pos=6&impt=1305598851.762569948275&zoneId=124http://web.adblade.com/clicks.php?appId=3243&zid=4da5904ab8406&adId=26507&pos=6&impt=1305598851.762569948275&zoneId=124http://web.adblade.com/clicks.php?appId=3243&zid=4d6ea146e4b12&adId=24942&pos=5&impt=1305598851.762569948275&zoneId=124http://web.adblade.com/clicks.php?appId=3243&zid=4d6ea146e4b12&adId=24942&pos=5&impt=1305598851.762569948275&zoneId=124http://www.smarterlifestyles.com/2010/06/01/the-advantages-of-buying-penny-stocks/?fc_id=26084&fc_app_id=3243http://www.smarterlifestyles.com/2010/06/01/the-advantages-of-buying-penny-stocks/?fc_id=26084&fc_app_id=3243http://web.adblade.com/clicks.php?appId=3243&zid=4da8600fd9bd4&adId=26620&pos=3&impt=1305598851.762569948275&zoneId=124http://web.adblade.com/clicks.php?appId=3243&zid=4da8600fd9bd4&adId=26620&pos=3&impt=1305598851.762569948275&zoneId=124http://web.adblade.com/clicks.php?appId=3243&zid=4dac6530672fa&adId=26664&pos=2&impt=1305598851.762569948275&zoneId=124http://web.adblade.com/clicks.php?appId=3243&zid=4dac6530672fa&adId=26664&pos=2&impt=1305598851.762569948275&zoneId=124http://web.adblade.com/clicks.php?appId=3243&zid=4da642c858d1e&adId=26552&pos=1&impt=1305598851.762569948275&zoneId=124http://web.adblade.com/clicks.php?appId=3243&zid=4da642c858d1e&adId=26552&pos=1&impt=1305598851.762569948275&zoneId=124

hiv combo + abbott award

Documents